20328 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole 1,3-Diazoles
TGR5 agonists
#1202Non-sedating antihistamine injection formulations and methods of use thereof
#1203Lipoprotein lipase-activating compositions comprising benzene derivates
#1204Methods and compositions for topoisomerase I modulated tumor suppression
#1205Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use
#1206Drug targets to overcome de novo drug-resistance in multiple myeloma
#1207TREATMENT OF DISEASE ASSOCIATED WITH THE USE OF ANTIBIOTICS
#1208Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
#1209Polymeric topical compositions
#1210Combination Therapy with an Antitumor Alkaloid
#1211ORAL METRONIDAZOLE PHARMACEUTICAL COMPOSITIONS
#1212DOSAGES OF ARYLSULFONAMIDE DERIVATIVES
#1213Control of Blood Vessel Physiology To Treat Skin Disorders
#1214Ophthalmic composition comprising ws-12 and methods to treat xerophthalmia
#1215Dexmedetomidine premix formulation
#12164-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mGluR 2/3 antagonists
#1217CONTROLLED RELEASE COMPOSITIONS
#1218COMBINATORIAL METHODS AND COMPOSITIONS FOR TREATMENT OF MELANOMA
#1219Compositions for increasing solubility of azole drug compounds that are poorly soluble in water
#1220Topical pharmaceutical compositions for treatment of skin damage
#1221Metronidazole esters for treating rosacea
#1222Imidazolidine-2,4-dione derivatives as N-formyl peptide receptor 2 modulators
#1223Prolylcarboxypeptidase inhibitors
#1224Compositions for treating infection
#1225L-ORNIDAZOLE FORMULATIONS AND THEIR APPLICATIONS IN TREATMENT OF PARASITIC INFECTIONS
#1226Compounds for treatment of cancer
#1227Methods and compositions for treating or preventing erythema
#1228Dual inhibitors of farnesyltransferase and geranylgeranyltransferase I
#1229Method for treating psoriasis
#12302,4,5-trisubstituted imidazoles and their use as anti-microbial agents
#1231Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
#1232Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
#1233Methods of treating hepatic encephalopathy
#1234Small Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof
#1235Treatment of depressive disorders
#1236N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
#1237Anti-Protozoal for Apicomplexan Protozoa
#1238Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions
#1239Compositions and Methods for the Treatment of Migraine
#1240Combretastatin analogs for use in the treatment of cancer
#1241METHOD OF TREATING SENSORIMOTOR DISORDERS WITH ALPHA-2 ADRENERGIC RECEPTOR AGONISTS
#1242Methods for treatment of sleep-related breathing disorders
#1243Preservative-free composition for topical use including hyaluronic acid
#1244Methods, compositions and kits for providing a therapeutic treatment
#1245SYNTHETIC TRITERPENOIDS AND TRICYCLIC-BIS-ENONES FOR USE IN STIMULATING BONE AND CARTILAGE GROWTH
#1246Long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesity
#1247Chemical compounds
#1248METHODS OF TREATING SKIN CONDITIONS EXHIBITING TELANGIECTASIA
#1249Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms
#1250METHODS OF TREATING PEDIATRIC PATIENTS USING DEXMEDETOMIDINE
#1251Methods involving aldose reductase inhibitors
#1252Compositions and Methods for Transmucosal Delivery of Lofexidine
#1253AGENT FOR TREATING HCV INFECTION
#1254COMPOUNDS FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASE
#1255AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA
#1256Personal care compositions and methods of making same
#1257OPHTHALMOLOGIC IRRIGATION SOLUTIONS AND METHOD
#1258Method of Treating Hair Loss Due to Systemic Chemotherapy
#1259Ophthalmologic irrigation solutions and method
#1260IMMUNOTHERAPEUTIC DOSING REGIMENS AND COMBINATIONS THEREOF
#1261Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
#1262Antimicrobial Compositions
#12633-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
#1264Composition and method for treating nosebleeds
#1265NEUROPROTECTIVE MODULATION OF NMDA RECEPTOR SUBTYPE ACTIVITIES
#1266Method of treatment using α-1-adrenergic agonist compounds
#1267Rosacea treatments and kits for performing them
#1268Non-sedating antihistamine injection formulations and methods of use thereof
#1269Topical tetracycline compositions
#1270COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR SURFACE ALLERGIES
#1271Methods involving aldose reductase inhibitors
#1272Antimicrobial compositions and methods of use thereof
#1273GASTRIC ACID SECRETION INHIBITING COMPOSITION
#1274Kinesin inhibitors as cancer therapeutics
#1275Compounds, compositions and methods for the treatment of islet amyloid polypeptide (IAPP) accumulation in diabetes
#1276Compositions and methods for treating lysosomal disorders
#1277Cyclopropanecarboxylic acid derivative
#1278Surfactant-free, water-free formable composition and breakable foams and their uses
#1279High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis
#1280Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations
#1281Methods of treating ulcerative colitis
#1282MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
#1283Oral antimicrobial pharmaceutical compositions
#1284Method for treating early severe diffuse acute respiratory distress syndrome
#1285Methods of inhibiting cataracts and presbyopia
#1286ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS
#1287Oral antimicrobial pharmaceutical compositions
#1288CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF
#1289Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#1290Hematopoietic growth factor mimetic small molecule compounds and their uses
#1291Non-sedating antihistamine injection formulations and methods of use thereof
#1292METHODS FOR TREATING METHYLMALONIC ACIDEMIA
#1293c-Kit antibodies and uses thereof
#1294USE OF N-AMINOIMIDAZOLE CYTOPROTECTIVE COMPOUNDS FOR TREATING CELL DEATH AND/OR GSK-3 MEDIATED DISEASES
#1295Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
#1296FECAL LACTOFERRIN AS A BIOMARKER FOR DETERMINING DISEASE SEVERITY AND FOR TREATING INFECTION IN PATIENTS WITH CLOSTRIDIUM DIFFICILE DISEASE
#1297FECAL LACTOFERRIN AS A BIOMARKER FOR DETERMINING DISEASE SEVERITY AND FOR MONITORING INFECTION IN PATIENTS WITH CLOSTRIDIUM DIFFICILE DISEASE
#1298Dual-acting antihypertensive agents
#1299Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#1300Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies
#1301METHODS OF TREATING FUNGAL INFECTIONS
#1302Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids
#1303N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl) arylsulfonamides
#1304Composition comprising benzoic acid in combination with organic acid preservatives as active ingredients and the use thereof
#1305Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
#1306Treatment of obesity, metabolic syndrome, and diabetes with protein kinase C inhibitors
#1307FRAGILE X MENTAL RETARDATION PROTEIN (FMRP), COMPOSITIONS, AND METHODS RELATED THERETO
#1308Compositions and methods for non-surgical treatment of ptosis
#1309Compositions and methods for non-surgical treatment of ptosis
#1310Compositions and Methods for Non-Surgical Treatment of Ptosis
#1311Synthetic triterpenoids and methods of use in the treatment of disease
#1312Benzimidazole-imidazole derivatives
#1313COSMETIC AND PHARMACEUTICAL COMPOSITIONS COMPRISING ACE INHIBITORS AND/OR ANGIOTENSIN II RECEPTOR ANTAGONISTS
#1314COMPOSITIONS AND METHODS FOR BIOACTIVE COATINGS TO IMPROVE ALLOGRAFT INCORPORATION
#1315Neprilysin inhibitors
#1316Pharmaceutical Cream Compositions of Oxymetazoline and Methods of Use
#1317Oral antimicrobial pharmaceutical compositions
#1318Compositions and methods for treating extracellular parasitic infections
#1319Treatment of cardiovascular disease and thrombosis
#1320Therapy for enteric infections
#1321Animal treatments
#1322METHODS AND USES OF CYTOCHROME P450 INHIBITORS
#1323Methods of treating hematologic cancers
#1324Method For The Prevention Of Cancer Metastasis
#1325Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic
#1326Compounds and methods for the modulation of sulfilimine bond formation
#1327Biotherapeutics for the treatment of infectious diseases
#1328Dual-acting imidazole antihypertensive agents
#1329Trimethylamine-containing compounds for diagnosis and prediction of disease
#1330Nasal Compositions and Uses Thereof
#1331Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases
#1332METHODS AND COMPOSITIONS FOR TREATING SKIN CONDITIONS ASSOCIATED WITH VASCULAR HYPER-REACTIVITY
#1333Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure
#1334Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions
#1335Methods of modulating uric acid levels
#1336PREPARATION OF FIPAMEZOLE
#1337Ester pro-drugs of [3-(1-(-imidazol-4-yl)ethyl)-2-methylphenyl] methanol
#1338PHARMACEUTICAL COMPOSITION COMBINING TENATOPRAZOLE AND A HISTAMINE H2-RECEPTOR ANTAGONIST
#1339Method of treating contrast-induced nephropathy
#1340Gastric Acid Secretion Inhibiting Composition
#1341Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
#1342Methods for evaluating and implementing prostate disease treatments
#1343Process for forming films, fibers, and beads from chitinous biomass
#1344Compositions for nail and skin treatment
#1345PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF SALICYLANILIDES FOR TREATMENT OF HEPATITIS VIRUSES
#1346Polymeric topical compositions
#1347Econazole composition and methods of treatment therewith
#1348Econazole composition and methods of treatment therewith
#1349Econazole composition and methods of treatment therewith
#1350COMPOSITIONS FOR TREATING CMT AND RELATED DISORDERS
#1351AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA
#1352ALPHA-2B RECEPTOR AGONIST AND ANTICONVULSANT COMPOSITIONS FOR TREATING CHRONIC PAIN
#1353CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF
#1354COMBINATION TREATMENT FOR DERMATOLOGICAL CONDITIONS
#1355RADIOPAQUE ANTIBIOTIC DENTAL PASTE AND USES THEREOF
#1356Metallo-β-lactamase inhibitors
#1357Antiviral drugs for treatment of arenavirus infection
#1358REMOVAL OF TOXINS FROM GASTROINTESTINAL FLUIDS
#1359MODULATING IRES-MEDIATED TRANSLATION
#1360-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
#1361COMPOSITIONS AND TREATMENT REGIMES FOR REDUCING INFLAMMATION, END-ORGAN INJURY, AND/OR SYSTEMIC ENDOTOXEMIA
#1362Nanoparticle-based tumor-targeted drug delivery
#1363N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
#1364NON-SEDATING ANTIHISTAMINE INJECTION FORMULATIONS AND METHODS OF USE THEREOF
#1365Solid pharmaceutical preparations containing copolymers based on polyethers combined with poorly water-soluble polymers
#1366COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED ALPHA-SYNUCLEIN FUNCTION
#1367METHOD FOR INHIBITING THE INDUCTION AND FORMATION OF OSTEOCLASTS
#1368COMBINATION THERAPY WITH PARP INHIBITORS
#1369NITROGEN AND SULFUR-CONTAINING HETROCYCLE DERIVATIVES
#1370Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
#1371Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders
#1372OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE
#1373Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
#1374Combination of compounds for treating or preventing skin diseases
#1375Once a day amoxicillin product comprising immediate and delayed release dosage forms
#1376COMPOSITIONS AND METHODS FOR DETECTING, TREATING, OR PREVENTING REDUCTIVE STRESS
#1377Compositions for treatment of skin and ear infections
#1378Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK
#1379Use of CB1 antagonists and/or inverse agonists for the preparation of drugs that increase motor neuron excitability
#1380Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System
#1381S1P receptors modulators and their use thereof
#1382Methods of Making and Using Stable Pharmaceutical Compositions Comprising Ketotifen and Naphazoline
#1383Inhibition of WDR5 interaction with its binding partners
#1384PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL
#1385Method for treating a B-raf associated cancer with an Hsp90 inhibitor
#1386Reducing platelet activation, aggregation and platelet-stimulated thrombosis or blood coagulation by reducing mitochondrial respiration
#1387Method for enhancing penetration of lipid insoluble medicaments through cell membranes using small S-Allyl-containing molecules with phospholipid permeability as carrier molecules
#1388Treatment or prevention of hypotension and shock
#1389ANTIBIOTIC THERAPY TO REDUCE THE LIKELIHOOD OF DEVELOPING POST-INFECTIOUS IRRITABLE BOWEL SYNDROME
#1390NEW DRUG FOR INHIBITING AGGREGATION OF PROTEINS INVOLVED IN DISEASES LINKED TO PROTEIN AGGREGATION AND/OR NEURODEGENERATIVE DISEASES
#1391TREATMENT OF VAGALLY-MEDIATED SPECTRUM DISORDERS
#1392Methods and compositions for treating or preventing erythema
#1393TREATMENT OF DEPRESSIVE DISORDERS
#1394Dual-acting antihypertensive agents
#1395Compositions, gels and foams with rheology modulators and uses thereof
#1396N-acyl anthranilic acid derivative or salt thereof
#1397Use Of Cationic Surfactants As Acaricidal Agents
#1398Nuclear export inhibitors of topoisomerase II alpha
#1399METHODS OF TREATING DERMATOLOGIC, GYNECOLOGIC, AND GENITAL DISORDERS WITH CAFFEIC ACID ANALOGS
#1400AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA
#1401Nitrogen and Sulfur-Containing Heterocycle Derivatives
#1402Fluorescent CDK inhibitors for treatment of cancer
#1403Partially microcellular, selectively hydrophilic composite construct for ocular drug delivery
#1404Triazolium and imidazolium salts and uses thereof
#1405Compounds for treatment of cancer
#1406METHOD FOR TOPICAL TREATMENT OF EYE DISEASE AND COMPOSITION AND DEVICE FOR SAID TREATMENT
#1407Methods to prevent and treat diseases
#1408METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#1409FAST DISSOLVING DRUG DELIVERY SYSTEMS
#1410USE OF CATIONIC SURFACTANTS FOR THE INACTIVATION OF TOXINS
#1411Composition for local anesthesia
#1412Na channels, disease, and related assays and compositions
#1413Methods of Treating or Preventing Acute Erythema
#1414Medicament and method of diagnosis for treating subclinical Cushing's syndrome
#1415Inhibitors of Dipeptidylpeptidase IV
#1416PHARMACEUTICAL COMPOSITION FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF DECUBITI AND FIRST DEGREE BURNS AND TREATMENT METHOD
#1417Method for solubilizing metronidazole
#1418Melt-Coated Dosage Forms
#1419PROCESS FOR PRODUCING PELLETS FOR PHARMACEUTICAL COMPOSITIONS
#1420PHARMACEUTICAL COMBINATION OF ANTIBACTERIAL AND ANTIFUNGAL CREAM
#1421Effervescent compositions comprising phosphonates and methods related thereto
#1422METHODS OF TREATING INFLAMMATORY CONDITIONS WITH ADRENERGIC ANTAGONISTS
#1423USE OF MULTI-PHARMACOPHORE COMPOUNDS TO TREAT NASAL DISORDERS
#1424NITRIC OXIDE RELEASING AMINO ACID ESTER COMPOUND, COMPOSITION AND METHOD OF USE
#1425METHODS FOR THE CLASSIFICATION AND DIAGNOSIS OF SCOLIOSIS THROUGH THE USE OF GI PROTEIN RECEPTOR
#1426Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
#1427TREATMENT OF LUNG CANCER
#1428APPETISING MEDICAMENTS FOR ORAL ADMINISTRATION IN SOLID FORM FOR PREVENTION AND/OR TREATMENT OF CARDIAC INSUFFICIENCY IN ANIMALS
#1429APPETISING MEDICAMENT FOR ORAL ADMINISTRATION IN SOLID FORM
#1430Methods and Compositions for Treating Alzheimer's Disease
#1431CONTROLLED RELEASE COMPOSITION
#1432Selenium-containing compounds
#1433Anti-viral drugs for treatment of arenavirus infection
#1434Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth
#1435USE OF MIFEPRISTONE FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#1436PHARMACEUTICAL COMPOSITION FOR USE IN TREATING SEXUALLY TRANSMITTED INFECTIONS
#1437Compositions and methods for treating lung disorders
#1438Novel Anti-Arrhythmia Agent
#1439Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
#1440Small molecule inhibitors for the treatment or prevention of dengue virus infection
#1441Use of interleukin 17E for the treatment of cancer
#14422,4,5-trisubstituted imidazoles and their use as anti-microbial agents
#1443COMBINATION THERAPY WITH PARP INHIBITORS
#1444Compositions and methods for ophthalmic delivery of nasal decongestants
#1445COMBINATION THERAPY WITH PARP INHIBITORS
#1446METHODS AND MATERIALS FOR GASTROINTESTINAL DELIVERY OF PATHOGEN/TOXIN BINDING AGENTS
#1447Methods and compositions for topoisomerase I modulated tumor suppression
#1448DELIVERY OF H2 ANTAGONISTS
#1449Method for treating psoriasis
#1450USE OF CNS PENETRATING ANTICANCER COMPOUNDS FOR THE TREATMENT OF PROTOZOAL DISEASES
#1451Substituted imidazole derivatives and methods of use thereof
#1452Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
#1453Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
#1454Gastric acid secretion inhibiting composition
#1455Skin Patches and Sustained-Release Formulations Comprising Lofexidine for Transdermal and Oral Delivery
#1456FORMULATION FOR PREVENTING OR REDUCING BLEEDING AT A SURGICAL SITE
#1457Dual-acting imidazole antihypertensive agents
#1458Combinations of imazalil and hydroxypyridones
#1459OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE
#1460Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water
#1461Anti-cancer drug
#1462Antifungal Drug Delivery System
#1463Sodium channel blocker delivery system with scleral lens
#1464SODIUM CHANNEL BLOCKER DELIVERY SYSTEM WITH SCLERAL LENS
#1465PERCUTANEOUS ABSORPTION PREPARATION
#1466Methods of use of antiviral compounds
#1467METHODS OF USE OF ANTIVIRAL COMPOUNDS
#1468LIPOPROTEIN LIPASE-ACTIVATING COMPOSITIONS COMPRISING BENZENE DERIVATIVES
#1469Retinamide and uses thereof
#147017BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-RELATED DISEASES
#1471METHOD FOR TREATING INFECTIONS
#1472N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors
#1473Nonsedating α-2 agonists
#1474Type III secretion inhibitors, analogs and uses thereof
#1475Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α-adrenoceptor agonists
#1476Solubilized benzoyl small molecule
#1477AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA
#1478METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS
#1479Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α-adrenoceptor agonists
#1480Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination
#1481LOFEXIDINE ENANTIOMERS FOR USE AS A TREATMENT FOR CNS DISEASE AND PATHOLOGIES AND ITS CHIRAL SYNTHESIS
#1482Nutraceutical Composition and Methods for Preventing or Treating Multiple Sclerosis
#1483ROSACEA TREATMENTS USING POLYMETAL COMPLEXES
#1484Non-sedating antihistamine injection formulations and methods of use thereof
#1485Compositions and methods for treatment of diseases and conditions associated with vasodilation and/or vascular leakage
#1486Non-sedating antihistamine injection formulations and methods of use thereof
#1487ORALLY RAPIDLY DISINTEGRATING TABLET COMPRISING IMIDAFENACIN
#1488PTEN Inhibitors Treat Neutropenia-Associated Pneumonia
#1489N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl)hetaryl arylsulfonamides
#1490TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH ANTIBODIES AGAINST CYTOTOXIC T LYMPHOCYTE-ASSOCIATED ANTIGEN 4 (CTLA4)
#1491Compounds as opioid receptor modulators
#1492METHODS AND COMPOSITIONS FOR INHIBITING PROLIFERATION OF ANEUPLOID CELLS
#1493Non-aqueous oil delivery system for ophthalmic drugs
#1494Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient
#1495Method for topical treatment of eye disease and composition and device for said treatment
#1496Nitric oxide amino acid ester compound, composition for increasing nitric oxide levels and method of use
#1497Ophthalmologic irrigation solutions and method
#1498Nutraceutical composition and methods for preventing or treating multiple sclerosis
#1499Dapsone to treat rosascea
#1500Pharmaceutical composition